ATE540125T1 - Verfahren und zusammensetzung zur stabilisierung flüssiger reagentien - Google Patents

Verfahren und zusammensetzung zur stabilisierung flüssiger reagentien

Info

Publication number
ATE540125T1
ATE540125T1 AT04811364T AT04811364T ATE540125T1 AT E540125 T1 ATE540125 T1 AT E540125T1 AT 04811364 T AT04811364 T AT 04811364T AT 04811364 T AT04811364 T AT 04811364T AT E540125 T1 ATE540125 T1 AT E540125T1
Authority
AT
Austria
Prior art keywords
solid
phase
assays
species
substrate
Prior art date
Application number
AT04811364T
Other languages
English (en)
Inventor
Roland Janzen
Carsten Schelp
Original Assignee
Siemens Healthcare Diagnostics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siemens Healthcare Diagnostics filed Critical Siemens Healthcare Diagnostics
Application granted granted Critical
Publication of ATE540125T1 publication Critical patent/ATE540125T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT04811364T 2003-11-24 2004-11-10 Verfahren und zusammensetzung zur stabilisierung flüssiger reagentien ATE540125T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/720,909 US20050112586A1 (en) 2003-11-24 2003-11-24 Method and composition for stabilizing liquid reagents
PCT/US2004/038637 WO2005052183A1 (en) 2003-11-24 2004-11-10 Method and composition for stabilizing liquid reagents

Publications (1)

Publication Number Publication Date
ATE540125T1 true ATE540125T1 (de) 2012-01-15

Family

ID=34591679

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04811364T ATE540125T1 (de) 2003-11-24 2004-11-10 Verfahren und zusammensetzung zur stabilisierung flüssiger reagentien

Country Status (6)

Country Link
US (2) US20050112586A1 (de)
EP (1) EP1702076B1 (de)
JP (1) JP2007512531A (de)
AT (1) ATE540125T1 (de)
ES (1) ES2379083T3 (de)
WO (1) WO2005052183A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102297963A (zh) * 2011-05-30 2011-12-28 吉权 一种胎膜早破胶体金试纸反应缓冲液及其制备方法
WO2015148735A1 (en) * 2014-03-25 2015-10-01 David Markus System and method for contact lens wireless communication
CN112703400B (zh) 2018-09-25 2024-10-15 美国西门子医学诊断股份有限公司 用于从使用环糊精阱的测定除去生物素干扰的方法和组合物
US11313855B2 (en) 2018-09-25 2022-04-26 Siemens Healthcare Diagnostics Inc. Methods and compositions for removing biotin interference from assays using conjugated molecular traps
EP4325221B1 (de) 2018-09-25 2025-10-29 Siemens Healthcare Diagnostics Inc. Molekülfalle zur entfernung von fluoreszeininterferenzen aus tests

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE337223B (de) * 1967-05-23 1971-08-02 Pharmacia Ab
GB1465519A (en) * 1973-07-31 1977-02-23 Nat Patent Dev Corp Sorbents coated with a synthetic solid water-insoluble hydro philic polymer
US4256834A (en) 1979-04-09 1981-03-17 Syva Company Fluorescent scavenger particle immunoassay
IT1199088B (it) 1984-03-09 1988-12-30 Miles Italiana Saggio di legame specifico mediante impiego di anti-g6pdh come marcante
US4914040A (en) 1988-03-03 1990-04-03 Boehringer Mannheim Gmbh Reagent and method for determination of a polyvalent substance using an immunoaggregate
US5039607A (en) * 1988-05-17 1991-08-13 Syntex (U.S.A.) Inc. Method for immunochromatographic analysis
DE3915135A1 (de) 1989-05-09 1990-11-15 Boehringer Mannheim Gmbh Verfahren zum nachweis spezifisch bindefaehiger substanzen in koerperfluessigkeiten
US6251581B1 (en) * 1991-05-22 2001-06-26 Dade Behring Marburg Gmbh Assay method utilizing induced luminescence
US5567591A (en) 1991-06-24 1996-10-22 Becton Dickinson And Company Amplified assay for analyte
DE4136010A1 (de) 1991-10-31 1993-08-12 Boehringer Mannheim Gmbh Verfahren zur bestimmung einer immunologisch bindefaehigen substanz
US6664114B1 (en) * 1992-08-03 2003-12-16 Sapidyne Instruments, Inc. Solid phase assay for detection of ligands
US5395938A (en) 1992-08-21 1995-03-07 Nichols Institute Diagnostics Biotinylated chemiluminescent labels and their conjugates, assays and assay kits
US6087188A (en) 1992-11-13 2000-07-11 Alk A/S Two-site immunoassay for an antibody with chemiluminescent label and biotin bound ligand
US5445936A (en) * 1993-09-15 1995-08-29 Ciba Corning Diagnostics Corp. Method for non-competitive binding assays
DE4343479A1 (de) 1993-12-21 1995-06-22 Boehringer Mannheim Gmbh Acylierte Proteinaggregate und deren Verwendung zur Entstörung von Immunoassays
CA2184386C (en) 1994-03-05 2005-10-18 Rosemarie Kientsch-Engel Interference eliminating agent for application in immunoassays
DE4407423A1 (de) 1994-03-05 1995-09-07 Boehringer Mannheim Gmbh Entstörmittel zum Einsatz bei Immunoassays
DE4439452A1 (de) 1994-11-04 1996-05-09 Boehringer Mannheim Gmbh Antikörperklassenspezifisches Entstörungsreagenz
JP2935578B2 (ja) 1994-12-19 1999-08-16 ベーリンガー マンハイム コーポレイション 改善された直線性を有する競合結合アッセイ
US6586193B2 (en) * 1996-04-25 2003-07-01 Genicon Sciences Corporation Analyte assay using particulate labels
US6303325B1 (en) 1998-05-29 2001-10-16 Dade Behring Inc. Method for detecting analytes
CA2424119A1 (en) * 2000-10-03 2002-04-11 Cynthia C. Bamdad Electronic detection of interaction and detection of interaction based on the interruption of flow

Also Published As

Publication number Publication date
EP1702076A4 (de) 2007-07-04
US20090208987A1 (en) 2009-08-20
JP2007512531A (ja) 2007-05-17
ES2379083T3 (es) 2012-04-20
WO2005052183A1 (en) 2005-06-09
US8252605B2 (en) 2012-08-28
US20050112586A1 (en) 2005-05-26
EP1702076A1 (de) 2006-09-20
EP1702076B1 (de) 2012-01-04

Similar Documents

Publication Publication Date Title
ATE415192T1 (de) Verfahren zur absorption von sauren gasen
DK1421389T3 (da) Neurofibrilmarkører
ATE335836T1 (de) Verfahren und kit zum nachweis von betalactam enthaltenden verbindungen
WO2008019086A3 (en) Detection of explosives, toxins and other compositions
EP1379693A4 (de) Auf oligonukleotid-modifizierten partikeln basierende bio-strichcodes
DE60330686D1 (de) Hydrophobe maldi-platte und verfahren zum hydrophobmachen einer maldi-platte
WO2008049134A3 (en) Method for s/tem sample analysis
CN102888215B (zh) 一种油基钻井液含油钻屑除油剂及制备方法
EP1915390A4 (de) Zusammensetzung und verfahren zur beobachtung und veränderung der proteinfaltung und löslichkeit
WO2006047182A8 (en) Method and apparatus for determining an analyte concentration in a sample having interferents
EP1702076A4 (de) Verfahren und zusammensetzung zur stabilisierung flüssiger reagentien
Quintana et al. Rapid and sensitive determination of ethylenediaminetetraacetic acid and diethylenetriaminepentaacetic acid in water samples by ion-pair reversed-phase liquid chromatography–electrospray tandem mass spectrometry
EA200500783A1 (ru) Комбинация для лечения синдрома дефицита внимания с гиперактивностью
ATE221657T1 (de) Entstörung durch rheumafaktoren
EP1830184A4 (de) Substrat für maldi-tof-ms und massenspektrometrisches verfahren unter verwendung davon
NO20081458L (no) Blanding av korrosjonsinhibitorer samt fremgangsmate ved bruk av samme
WO2007037898A8 (en) Theramutein modulators
DE60228952D1 (de) Nachweis von Legionella durch ein PCR und FRET verwendendes Verfahren
DE502004011832D1 (de) Verfahren zur Verschiebung von Sauergasanteilen innerhalb eines Erdgasnetzwerkes
JP4958500B2 (ja) カルシウム濃度測定試薬および測定方法
WO2005111231A3 (en) Compositions, kit and one-step method for monitoring compounds having anti-factor xa and/or anti factor iia activities
DE60138111D1 (de) Verfahren zur reinigung eines kalziumionen-bindenden proteins
Scandurra et al. Chemistry of green encapsulating molding compounds at interfaces with other materials in electronic devices
WO2008054354A3 (en) Assays for s1oo inhibitors
RU2006132540A (ru) Состав для удаления асфальтно-смоло-парафиновых отложений